A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial
Publication
, Conference
Harrison, JK; Hermiller, JB; Vetrovec, GW; Smith, JE; Pulsipher, MW; Kern, MJ; Conn, EH; Navetta, FI; She, L; Pieper, K; Sketch, MH ...
Published in: CIRCULATION
October 28, 2003
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
354 / 355
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrison, J. K., Hermiller, J. B., Vetrovec, G. W., Smith, J. E., Pulsipher, M. W., Kern, M. J., … Davidson, C. J. (2003). A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial. In CIRCULATION (Vol. 108, pp. 354–355). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS.
Harrison, J. K., J. B. Hermiller, G. W. Vetrovec, J. E. Smith, M. W. Pulsipher, M. J. Kern, E. H. Conn, et al. “A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial.” In CIRCULATION, 108:354–55. LIPPINCOTT WILLIAMS & WILKINS, 2003.
Harrison JK, Hermiller JB, Vetrovec GW, Smith JE, Pulsipher MW, Kern MJ, et al. A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 354–5.
Harrison, J. K., et al. “A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial.” CIRCULATION, vol. 108, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2003, pp. 354–55.
Harrison JK, Hermiller JB, Vetrovec GW, Smith JE, Pulsipher MW, Kern MJ, Conn EH, Navetta FI, She L, Pieper K, Sketch MH, Tcheng JE, Davidson CJ. A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 354–355.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
354 / 355
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology